{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:17Z","timestamp":1792839737472,"version":"4.5.0"},"reference-count":50,"publisher":"BMJ","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"accepted":{"date-parts":[[2023,6,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Population based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>British Columbia, Scotland, and England (England cohort consists of patients with cirrhosis only).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>21\u2009790 people who were successfully treated for hepatitis C in the era of interferon-free antivirals (2014-19). Participants were divided into three liver disease severity groups: people without cirrhosis (pre-cirrhosis), those with compensated cirrhosis, and those with end stage liver disease. Follow-up started 12 weeks after antiviral treatment completion and ended on date of death or 31 December 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Crude and age-sex standardised mortality rates, and standardised mortality ratio comparing the number of deaths with that of the general population, adjusting for age, sex, and year. Poisson regression was used to identify factors associated with all cause mortality rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1572 (7%) participants died during follow-up. The leading causes of death were drug related mortality (n=383, 24%), liver failure (n=286, 18%), and liver cancer (n=250, 16%). Crude all cause mortality rates (deaths per 1000 person years) were 31.4 (95% confidence interval 29.3 to 33.7), 22.7 (20.7 to 25.0), and 39.6 (35.4 to 44.3) for cohorts from British Columbia, Scotland, and England, respectively. All cause mortality was considerably higher than the rate for the general population across all disease severity groups and settings; for example, all cause mortality was three times higher among people without cirrhosis in British Columbia (standardised mortality ratio 2.96, 95% confidence interval 2.71 to 3.23; P&lt;0.001) and more than 10 times higher for patients with end stage liver disease in British Columbia (13.61, 11.94 to 15.49; P&lt;0.001). In regression analyses, older age, recent substance misuse, alcohol misuse, and comorbidities were associated with higher mortality rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mortality rates among people successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals are high compared with the general population. Drug and liver related causes of death were the main drivers of excess mortality. These findings highlight the need for continued support and follow-up after successful treatment for hepatitis C to maximise the impact of direct acting antivirals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmj-2022-074001","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T20:05:34Z","timestamp":1691006734000},"page":"e074001","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study"],"prefix":"10.1136","volume":"382","author":[{"given":"Victoria","family":"Hamill","sequence":"first","affiliation":[{"name":"School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK"},{"name":"Public Health Scotland, Glasgow, UK"},{"name":"Joint first authors"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Wong","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Joint first authors"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Benselin","sequence":"additional","affiliation":[{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK"},{"name":"Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C","family":"Hayes","sequence":"additional","affiliation":[{"name":"Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mutimer","sequence":"additional","affiliation":[{"name":"Liver and Hepatology Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Yu","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Dillon","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gelson","sequence":"additional","affiliation":[{"name":"Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector A","family":"Vel\u00e1squez Garc\u00eda","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Yeung","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK"},{"name":"Public Health Scotland, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T","family":"Barclay","sequence":"additional","affiliation":[{"name":"Glasgow Royal Infirmary, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alvarez","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fraser","sequence":"additional","affiliation":[{"name":"Aberdeen Royal Infirmary, Aberdeen, UK"},{"name":"Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bartlett","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Aldersley","sequence":"additional","affiliation":[{"name":"Leeds Liver Unit, St James\u2019s University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Bathgate","sequence":"additional","affiliation":[{"name":"Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawuena","family":"Binka","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[{"name":"Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne R","family":"Morling","sequence":"additional","affiliation":[{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK"},{"name":"Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, UK"},{"name":"Lifespan and Population Health, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D","family":"Ryder","sequence":"additional","affiliation":[{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hutchinson","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK"},{"name":"Public Health Scotland, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine and the Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra Neil","family":"Guha","sequence":"additional","affiliation":[{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK"},{"name":"Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L","family":"Irving","sequence":"additional","affiliation":[{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK"},{"name":"Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Z","family":"Janjua","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Centre for Health Evaluation and Outcome Sciences, St Paul\u2019s Hospital Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0565-1083","authenticated-orcid":false,"given":"Hamish","family":"Innes","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK"},{"name":"Public Health Scotland, Glasgow, UK"},{"name":"Lifespan and Population Health, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"2025110102160574000_382.aug02_9.e074001.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.006"},{"key":"2025110102160574000_382.aug02_9.e074001.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360730"},{"key":"2025110102160574000_382.aug02_9.e074001.3","unstructured":"Hopwood M Treloar C Resull L . Experiences of hepatitis C treatment and its management: what some patients and health professionals say (Monograph 4\/2006). National Centre in HIV Social Research, The University of New South Wales, 2006."},{"key":"2025110102160574000_382.aug02_9.e074001.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00941.x"},{"key":"2025110102160574000_382.aug02_9.e074001.5","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835201a4"},{"key":"2025110102160574000_382.aug02_9.e074001.6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15780"},{"key":"2025110102160574000_382.aug02_9.e074001.7","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15143"},{"key":"2025110102160574000_382.aug02_9.e074001.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.001"},{"key":"2025110102160574000_382.aug02_9.e074001.9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29685"},{"key":"2025110102160574000_382.aug02_9.e074001.10","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14779"},{"key":"2025110102160574000_382.aug02_9.e074001.11","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. Switzerland: World Health Organization; 2016. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf"},{"key":"2025110102160574000_382.aug02_9.e074001.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.028"},{"key":"2025110102160574000_382.aug02_9.e074001.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32111-1"},{"key":"2025110102160574000_382.aug02_9.e074001.14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27766"},{"key":"2025110102160574000_382.aug02_9.e074001.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.12627"},{"key":"2025110102160574000_382.aug02_9.e074001.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.034"},{"key":"2025110102160574000_382.aug02_9.e074001.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.004"},{"key":"2025110102160574000_382.aug02_9.e074001.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.013"},{"key":"2025110102160574000_382.aug02_9.e074001.19","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1683-z"},{"key":"2025110102160574000_382.aug02_9.e074001.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150176"},{"key":"2025110102160574000_382.aug02_9.e074001.21","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12153"},{"key":"2025110102160574000_382.aug02_9.e074001.22","unstructured":"McLeod A Glancy M Went A . Surveillance of hepatitis C testing, diagnosis and treatment in Scotland, 2019 update. Scotland. NHS, 2019."},{"key":"2025110102160574000_382.aug02_9.e074001.23","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw362"},{"key":"2025110102160574000_382.aug02_9.e074001.24","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx015"},{"key":"2025110102160574000_382.aug02_9.e074001.25","unstructured":"Diagnostic Imaging Dataset NHS . 2012. Available from: https:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/diagnostic-imaging-dataset\/"},{"key":"2025110102160574000_382.aug02_9.e074001.26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz076"},{"key":"2025110102160574000_382.aug02_9.e074001.27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27366"},{"key":"2025110102160574000_382.aug02_9.e074001.28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir076"},{"key":"2025110102160574000_382.aug02_9.e074001.29","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2025110102160574000_382.aug02_9.e074001.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"2025110102160574000_382.aug02_9.e074001.31","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433"},{"key":"2025110102160574000_382.aug02_9.e074001.32","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/28.5.964"},{"key":"2025110102160574000_382.aug02_9.e074001.33","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15528"},{"key":"2025110102160574000_382.aug02_9.e074001.34","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13737"},{"key":"2025110102160574000_382.aug02_9.e074001.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049713"},{"key":"2025110102160574000_382.aug02_9.e074001.36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"2025110102160574000_382.aug02_9.e074001.37","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13965"},{"key":"2025110102160574000_382.aug02_9.e074001.38","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac292"},{"key":"2025110102160574000_382.aug02_9.e074001.39","unstructured":"BC Gov News. BC introduces new prescribed safer supply policy, a Canadian first. 2021. Available from: https:\/\/news.gov.bc.ca\/releases\/2021MMHA0035-001375"},{"key":"2025110102160574000_382.aug02_9.e074001.40","unstructured":"BC Gov News. BC receives exemption to decriminalize possession of some illegal drugs for personal use. 2022. Available from: https:\/\/news.gov.bc.ca\/releases\/2022MMHA0029-000850"},{"key":"2025110102160574000_382.aug02_9.e074001.41","unstructured":"UK Health Security Agency. Hepatitis C in England 2022. Working to eliminate hepatitis C as a public health problem. Full report. England (UK): UK Health Security Agency; 2022. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1057271\/HCV-in-England-2022-full-report.pdf"},{"key":"2025110102160574000_382.aug02_9.e074001.42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29419"},{"key":"2025110102160574000_382.aug02_9.e074001.43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28458"},{"key":"2025110102160574000_382.aug02_9.e074001.44","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S43926"},{"key":"2025110102160574000_382.aug02_9.e074001.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.06.016"},{"key":"2025110102160574000_382.aug02_9.e074001.46","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14227"},{"key":"2025110102160574000_382.aug02_9.e074001.47","unstructured":"Health Protection Scotland and the Scottish Government. The Scottish Government hepatitis C treatment and therapies group report. Scotland (UK): The Scottish Government; 2017. Available from: https:\/\/www.gcu.ac.uk\/__data\/assets\/pdf_file\/0020\/28901\/hepc_treatment_report_feb2017.pdf"},{"key":"2025110102160574000_382.aug02_9.e074001.48","unstructured":"NHS England Clinical Reference Group for Infectious Diseases. Clinical commissioning policy statement: treatment of chronci hepatitis C in patients with cirrhosis. England (UK): NHS England; 2015. Available from: https:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2015\/06\/hep-c-cirrhosis-polcy-statmnt-0615.pdf"},{"key":"2025110102160574000_382.aug02_9.e074001.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.038"},{"key":"2025110102160574000_382.aug02_9.e074001.50","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30182-0"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2022-074001","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2022-074001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:16:14Z","timestamp":1761988574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2022-074001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":50,"alternative-id":["10.1136\/bmj-2022-074001"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2022-074001","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]}}}